353
Views
15
CrossRef citations to date
0
Altmetric
Articles

The Effects of Synbiotic Supplementation on Antioxidant Capacity and Arm Volumes in Survivors of Breast Cancer-Related Lymphedema

, , , , ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 62-73 | Received 19 Mar 2019, Accepted 05 May 2019, Published online: 28 May 2019

References

  • Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram‐Baptiste D, et al: Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 68, 297–316, 2018.
  • Silva AK, and Chang DW: Vascularized lymph node transfer and lymphovenous bypass: novel treatment strategies for symptomatic lymphedema. J Surg Oncol 113, 932–939, 2016.
  • Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, and Boughey JC: Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study. Ann Surg Oncol 24, 2972–2980, 2017.
  • Brayton KM, Hirsch AT, Patricia J, Cheville A, Karaca-Mandic P, et al. Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs. PLoS One 9, e114597, 2014.
  • Fu MR, Axelrod D, Guth AA, Fletcher J, Qiu JM, et al. Patterns of obesity and lymph fluid level during the first year of breast cancer treatment: a prospective study. J Pers Med 5, 326–340, 2015.
  • Helyer LK, Varnic M, Le LW, Leong W, and McCready D: Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 16, 48–54, 2010. 2010
  • Mehrara BJ, and Greene AK: Lymphedema and obesity: is there a link? Plast Reconstr Surg 134, 154e, 2014.
  • Zampell JC, Aschen S, Weitman ES, Yan A, Elhadad S, et al. Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation. Plast Reconstr Surg 129, 825, 2012.
  • Weitman ES, Aschen SZ, Farias-Eisner G, Albano N, Cuzzone DA, et al. Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes. PloS One 8, e70703, 2013.
  • Lim HY, Rutkowski JM, Helft J, Reddy ST, Swartz MA, et al. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am J Pathol 175, 1328–1337, 2009.
  • Panis C, Herrera A, Victorino V, Campos F, Freitas L, et al. Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat 133, 89–97, 2012.
  • Hayes SC, Janda M, Cornish B, Battistutta D, and Newman B: Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 26, 3536–3542, 2008.
  • Reuter S, Gupta S, Chaturvedi M, and Aggarwal B: Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49, 1603–1616, 2010.
  • Visconti R, and Grieco D: New insights on oxidative stress in cancer. Curr Opin Drug Discov Devel 12, 240–245, 2009.
  • Schetter AJ, Heegaard NH, and Harris CC: Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31, 37–49, 2010.
  • Aggarwal BB, Vijayalekshmi R, and Sung B: Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 15, 425–430, 2009.
  • Schrezenmeir J, and de Vrese M: Probiotics, prebiotics, and synbiotics-approaching a definition–. Am J Clin Nutr 73, 361S–364s, 2001.
  • Vieira AT, Fukumori C, and Ferreira CM: New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases. Clin Transl Immunology 5, e87, 2016.
  • Plaza-Díaz J, Ruiz-Ojeda F, Vilchez-Padial L, and Gil A: Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases. Nutrients 9, 555, 2017.
  • Ringel Y, and Carroll IM: Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointest Endosc Clin N Am 19, 141–150, 2009.
  • Kim H, Chae H, Jeong S, Ham J, Im S, et al. In vitro antioxidative properties of lactobacilli. Asian Australas J Anim Sci 19, 262–265, 2005.
  • Zamani B, Farshbaf S, Golkar HR, Bahmani F, and Asemi Z: Synbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial. Br J Nutr 117, 1095–1102, 2017.
  • Zamani B, Golkar HR, Farshbaf S, Emadi‐Baygi M, et al. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double‐blind, placebo‐controlled trial. Int J Rheum Dis 19, 869–879, 2016.
  • Gomes AC, de Sousa RGM, Botelho PB, Gomes TLN, Prada PO, et al. The additional effects of a probiotic mix on abdominal adiposity and antioxidant Status: a double‐blind, randomized trial. Obesity 25, 30–38, 2017.
  • Mishra V, Shah C, Mokashe N, Chavan R, Yadav H, et al. Probiotics as potential antioxidants: a systematic review. J Agric Food Chem 63, 3615–3626, 2015.
  • Vasheghani-Farahani A, Tahmasbi M, Asheri H, Ashraf H, Nedjat S, et al. The Persian, last 7-day, long form of the International Physical Activity Questionnaire: translation and validation study. Asian J Sports Med 2, 1062011.
  • Durnin JV, and Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32, 77–97, 1974.
  • Kootstra JJ, Hoekstra-Weebers JE, Rietman JS, de Vries J, Baas PC, et al. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection. Ann Surg Oncol 17, 2384–2394, 2010.
  • Petrek JA, and Heelan MC: Incidence of breast carcinoma-related lymphedema. Cancer 83, 2776–2781, 1998.
  • Siems W, Brenke R, Beier A, and Grune T: Oxidative stress in chronic lymphoedema. QJM 95, 803–809, 2002.
  • Ghoneim MA, and Moselhy SS: Antioxidant status and hormonal profile reflected by experimental feeding of probiotics. Toxicol Ind Health 32, 741–750, 2016.
  • Bahmani F, Tajadadi-Ebrahimi M, Kolahdooz F, Mazouchi M, Hadaegh H, et al. The consumption of synbiotic bread containing Lactobacillus sporogenes and inulin affects nitric oxide and malondialdehyde in patients with type 2 diabetes mellitus: randomized, double-blind, placebo-controlled trial. J Am Coll Nutr 35, 506–513, 2016.
  • Del Rio D, Stewart AJ, and Pellegrini N: A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15, 316–328, 2005.
  • Shakeri H, Hadaegh H, Abedi F, Tajabadi-Ebrahimi M, Mazroii N, et al. Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes. Lipids 49, 695–701, 2014.
  • Wang Y, Li Y, Xie J, Zhang Y, Wang J, et al. Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. Int Immunopharmacol 15, 30–37, 2013.
  • Samah S, Ramasamy K, Lim SM, and Neoh CF: Probiotics for the management of type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract 118, 172–182, 2016.
  • Ebrahimi-Mameghani M, Sanaie S, Mahmoodpoor A, and Hamishehkar H: Effect of a probiotic preparation (VSL# 3) in critically ill patients: a randomized, double-blind, placebo-controlled trial (Pilot Study). Pak J Med Sci 29, 490, 2013.
  • Mishra V, Baines M, Wenstone R, and Shenkin A: Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem 42, 269–276, 2005.
  • Rock CL, Doyle C, Demark‐Wahnefried W, Meyerhardt J, Courneya KS, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62, 242–274, 2012.
  • Karamali M, Eghbalpour S, Rajabi S, Jamilian M, Bahmani F, et al. Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Arch Iran Med (AIM) 21, 1–7, 2018.
  • Alacacioglu A, Kebapcilar L, Onder Pamuk B, Sop G, Kucukiravul C, et al. Oxidative and antioxidative status after anthracyclinebased chemotherapy in breast cancer patients. J BUON 18, 614–618, 2013.
  • Achuthan AA, Duary RK, Madathil A, Panwar H, Kumar H, et al. Antioxidative potential of lactobacilli isolated from the gut of Indian people. Mol Biol Rep 39, 7887–7897, 2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.